REG4 promotes peritoneal metastasis of gastric cancer through GPR37
Hexiao Wang(Memorial Sloan Kettering Cancer Center), Qiumeng Yang(Shanghai Jiao Tong University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Min Yan(Zhengzhou University), Mingde Zang(Fudan University Shanghai Cancer Center), Liping Su(Guangdong Provincial People's Hospital), Lei Hu(Anhui Medical University), Jianfang Li(Shanghai Jiao Tong University), Yantao Duan(Shanghai Medical College of Fudan University), Bingya Liu(Shanghai Jiao Tong University), Zhiyuan Fan(Shanghai First Maternity and Infant Hospital)
Cited by 77
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2019|231
Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
|World Journal of Gastroenterology|2018|212